Seizure possibly associated with fluvoxamine

OBJECTIVE: To inform clinicians of the possibility that seizures due to the rapeutic doses of fluvoxamine may not be as rare as previously considered. CASE SUMMARY: A 49-year-old white man with schizoaffective disorder and a p ast history of seizures secondary to head trauma had been seizure-free for approximately 10 years. Fluvoxamine therapy was begun due to increasing obs essive-compulsive behavior. Despite receiving anticonvulsants for this mood disorder, the patient had a breakthrough seizure. There were no underlying medical conditions that might have induced this seizure. No further seizur es occurred after he was placed on a higher dosage of the anticonvulsants. The obsessive-compulsive behavior improved considerably as a result of fluv oxamine treatment. DISCUSSION: The patient presented here developed a seizure with a therapeut ic dosage of fluvoxamine; seizures associated with this agent have occurred more often with overdose. Multiple factors such as a prior history of seiz ures, head trauma, and concurrent treatment with other psychotropic agents are considered in this case report. CONCLUSIONS: Despite the relatively safe and benign adverse effect profile of the selective serotonin-reuptake inhibitors such as fluvoxamine, clinici ans should be cautious about seizures as an adverse effect, especially when the patient has even a remote history of seizure or head trauma.